RedShiftBio Appoints Topbiox as Exclusive Distributor in China

RedShift BioAnalytics, Inc announces its award winning AQS3™pro, based on Microfluidic Modulation Spectroscopy (MMS) technology, is now available in China, following the appointment of Beijing-based Topbiox as exclusive distributor. Designed specifically for protein characterisation applications in the biopharmaceutical industry, the technology has already seen wide adoption in the analytical toolkit of companies developing life-saving biotherapeutics and vaccines.

“Topbiox is an experienced distributor of biophysical characterisation tools in China. Its reputation for providing the highest quality instrumentation, service and applications support to its customers make it a perfect partner to us,”, said Julien Bradley, CEO RedShiftBio.

Topbiox works closely with the Chinese biopharmaceutical industry to refine its instrumentation range to closely match industry requirements. It was looking to add a technique that enables teams to perform multiple secondary structure measurements on one instrument, without the need for specially qualified staff. "This collaboration complements our existing products and enhances our protein characterisation product line,” said Sean Shi, General Manager Topbiox. “With Microfluidic Modulation Spectroscopy, Chinese scientists can analyse their samples more efficiently and accurately. We are very excited to collaborate with RedShiftBio to provide our customers with the advanced AQS3pro."

The partnership means that Chinese scientists can now experience demonstrations and run samples onsite. Topbiox will be responsible for all sales, marketing, service and support.